Allarity Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Allarity Therapeutics, Inc. (ALLR) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 5.10% as of 2024-03-14, per its 10-Q filed 2024-05-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2024-05-14
- Allarity Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-03-31 was 2.40%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month |
|---|---|---|---|---|---|---|
| 2024-03-14 | 5.10% 10-Q · filed 2024-05-14 | |||||
| 2024-02-14 | 5.05% 10-Q · filed 2024-05-14 | |||||
| 2024-01-14 | 4.82% 10-Q · filed 2024-05-14 | |||||
| 2023-12-31 | 3.84% 10-K · filed 2024-03-08 | |||||
| 2023-12-05 | 4.14% 10-K · filed 2024-03-08 | |||||
| 2023-12-01 | 4.14% 10-K · filed 2024-03-08 | |||||
| 2023-11-08 | 4.14% 10-K · filed 2024-03-08 | |||||
| 2023-09-30 | 4.52% 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 4.20% 10-Q · filed 2023-08-14 | |||||
| 2023-04-21 | 3.70% 10-K · filed 2024-03-08 | 3.70% 10-Q · filed 2023-08-14 | ||||
| 2022-09-30 | 3.05% 10-Q · filed 2022-11-14 | |||||
| 2022-03-31 | 2.40% 10-Q · filed 2023-05-11 | |||||
| 2021-12-20 | 0.91% 10-K · filed 2022-05-17 | |||||
| 2021-09-30 | 0.50% 10-Q/A · filed 2022-05-17 | |||||
| 2021-09-13 | 0.50% 10-K · filed 2022-05-17 | |||||
| 2021-06-30 | 0.56% 10-Q/A · filed 2022-05-17 | |||||
| 2021-06-24 | 0.55% 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |